Farydak (panobinostat) Capsules

Medical Evidence

Generic name : Panobinostat.

Trade name : Farydak.

Manufacturer name :

Farydak” is manufactured by Novartis Pharmaceuticals Corporation.

Farydak FDA Approval :

Farydak first approved February 23rd, 2015.

Dosage form :

Capsules: 10 mg, 15 mg, and 20 mg.

Indications and usage :

• Multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent.
• Relapsed and refractory multiple myeloma.

Farydak (Panobinostat) Capsules availability in India

• You could import this medicine against import permit on Patient Name.
• Please contact ACT Lifesciences Private Limited for further information.